4-iodo-2-nitrobenzaldehyde | 60184-79-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-iodo-2-nitrobenzaldehyde
• 英文别名: 4-Jod-2-nitro-benzaldehyd
• CAS: 60184-79-4
• 化学式: C₇H₄INO₃
• 分子量: 277.018
• InChiKey: XLTSVKXVJZWHGB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  62.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-iodo-2-nitrobenzaldehyde 在 kryptofix 222 、 碘苯二乙酸 、 potassium hydrogencarbonate 作用下， 以 二甲基亚砜 、 乙腈 为溶剂， 反应 0.58h， 生成 N-succinimidyl 2-[¹⁸F]fluoro-4-iodobenzoate
  参考文献：
  名称：

  [¹⁸F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)

  摘要：

  Radiolabeled urea-based low-molecular weight inhibitors of the prostate-specific membrane antigen (PSMA) are under intense investigation as imaging and therapeutic agents for prostate and other cancers. In an effort to provide agents with less nontarget organ uptake than the ureas, we synthesized four F-18-labeled inhibitors of PSMA based on carbamate scaffolds. 4-Bromo-2-[F-18]fluorobenzoyllysineoxypentanedioic acid (OPA) carbamate [F-18]23 and 4-iodo-2-[F-18]fluorobenzoyllysine OPA carbamate [F-18]24 in particular exhibited high target-selective uptake in PSMA+ PC3 PIP tumor xenografts, with tumor-to-kidney ratios of >1 by 4 h postinjection, an important benchmark. Because of its high tumor uptake (90% injected dose per gram of tissue at 2 h postinjection) and high tumor-to-organ ratios, [F-18]23 is promising for clinical translation. Prolonged tumor-specific uptake demonstrated by [F-18]24, which did not reach equilibrium during the 4 h study period, suggests carbamates as alternative scaffolds for mitigating dose to nontarget tissues.

  DOI：

  10.1021/acs.jmedchem.5b01268
• 作为产物：
  描述：

  4-甲基-3-硝基苯胺 在 N-溴代丁二酰亚胺(NBS) 、 硫酸 、 碳酸氢钠 、 sodium chloride 、 sodium nitrite 、 过氧化苯甲酰 作用下， 以 四氯化碳 、 水 、 二甲基亚砜 为溶剂， 反应 19.75h， 生成 4-iodo-2-nitrobenzaldehyde
  参考文献：
  名称：

  Nucleotides and nucleosides and methods for their use in DNA sequencing

  摘要：

  本发明一般涉及带标记和未标记的可切割终止基团以及用于DNA测序和其他类型的DNA分析的方法。更具体地，该发明部分涉及具有化学可切割、光解可切割、酶可切割或非光解可切割基团的核苷酸和核苷以及它们在DNA测序中的使用方法及其在生物医学研究中的应用。

  公开号：

  US09200319B2

文献信息

• Novel functionalized indigo derivatives for organic electronics
  作者：Irina V. Klimovich、Alexander V. Zhilenkov、Lidiya I. Кuznetsova、Lubov A. Frolova、Olga R. Yamilova、Sergey I. Troyanov、Konstantin A. Lyssenko、Pavel A. Troshin

  DOI：10.1016/j.dyepig.2020.108966

  日期：2021.2

  A series of nine novel indigo derivatives, including diiodoindigo, octahalogenated indigoids and compounds with extended π-conjugated system, were synthesized, characterized and investigated as semiconductor materials in organic field-effect transistors (OFETs). Among them, 6,6'-diiodoindigo demonstrated the ambipolar behavior with balanced p-type and n-type mobilities. The complete substitution of

  合成，表征并研究了九种新颖的靛蓝衍生物系列，包括二碘靛蓝，八ahalogenized靛蓝和具有扩展π共轭体系的化合物，并作为有机场效应晶体管（OFET）中的半导体材料进行了研究。其中6,6'-二碘靛显示出平衡的p型和n型迁移率的双极性行为。靛蓝核上的氢被卤素原子完全取代，导致OFET中的电子迁移率低。通过引入小的芳族取代基（噻吩和苯基）对共轭体系的扩展导致了主要的p型行为。芳环的融合导致z形的二苯并靛蓝，由于分子在晶格中沿彼此的非最佳排列而显示出较差的电荷传输性能。基于取代基的化学性质与其在靛蓝核心处的位置，材料的光电特性及其在OFET中的性能之间的关系，所获得的数据符合先前报道的模型。这项研究的结果将有助于合理设计新一代用于生物相容性有机电子的基于靛蓝的半导体。
• Diphenyl ether derivatives and their use for imaging serotonin transporters
  申请人：Kung F. Hank

  公开号：US20060083680A1

  公开（公告）日：2006-04-20

  This invention relates to diphenyl ether derivatives and their use in imaging of Serotonin Transporters (SERTS). The present invention also provides diagnostic compositions comprising the compounds of the present invention, and a pharmaceutically acceptable carrier or diluent. The invention further provides a method of imaging SERTS, comprising introducing into a patient a detectable quantity of a labeled compound of the present invention, or a pharmaceutically acceptable salt, ester, amide or prodrug thereof, allowing sufficient time for the labeled compound to associate with one or more SERTs, and detecting the labeled compound. The present invention can also be used to follow the progression of a disease associated with SERTs or a therapy that targets SERTs.

  本发明涉及二苯醚衍生物及其在血清素转运体（SERTS）成像中的应用。本发明还提供了包含本发明化合物的诊断组合物，并且还提供了一种含有药学上可接受的载体或稀释剂的成像SERTS的方法，该方法包括向患者引入本发明的标记化合物或其药学上可接受的盐，酯，酰胺或前药的可检测量，允许足够的时间使标记化合物与一个或多个SERTS结合，并检测标记化合物。本发明还可用于跟踪与SERTS相关的疾病的进展或针对SERTS的治疗。
• NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN DNA SEQUENCING
  申请人：LITOSH Vladislav A.

  公开号：US20100041041A1

  公开（公告）日：2010-02-18

  The present invention relates generally to labeled and unlabled cleavable terminating groups and methods for DNA sequencing and other types of DNA analysis. More particularly, the invention relates in part to nucleotides and nucleosides with chemically cleavable, photocleavable, enzymatically cleavable, or non-photocleavable groups and methods for their use in DNA sequencing and its application in biomedical research.

  本发明涉及标记和未标记的可断裂终止基团以及用于DNA测序和其他类型的DNA分析的方法。更具体地，本发明部分涉及具有化学可断裂、光解、酶解或非光解基团的核苷酸和核苷以及它们在DNA测序中的使用及其在生物医学研究中的应用。
• Nucleotides and Nucleosides and Methods for their Use in DNA Sequencing
  申请人：Litosh Vladislav A.

  公开号：US20130035237A1

  公开（公告）日：2013-02-07

  The present invention relates generally to labeled and unlabled cleavable terminating groups and methods for DNA sequencing and other types of DNA analysis. More particularly, the invention relates in part to nucleotides and nucleosides with chemically cleavable, photocleavable, enzymatically cleavable, or non-photocleavable groups and methods for their use in DNA sequencing and its application in biomedical research.

  本发明通常涉及带有标记和未标记的可断裂终止基团及其在DNA测序和其他类型的DNA分析中的方法。更具体地，本发明部分涉及具有化学可断裂、光解、酶解或非光解基团的核苷酸和核苷以及它们在DNA测序中的应用及其在生物医学研究中的应用方法。
• Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
  申请人：THE JOHNS HOPKINS UNIVERSITY

  公开号：US10736974B2

  公开（公告）日：2020-08-11

  Carbamate and beta-amino acid urea-based scaffolds that have high binding affinity to PSMA are disclosed. These scaffolds can be radiolabeled and used for imaging cells and tumors that express PSMA or for cancer radiotherapy. These compounds also can comprise a fluorescent dye and be used for imaging cells and tumors that express PSMA or for photodynamic therapy.

  本发明公开了与 PSMA 具有高结合亲和力的氨基甲酸酯和β-氨基酸脲基支架。这些支架可进行放射性标记，用于表达 PSMA 的细胞和肿瘤成像或癌症放射治疗。这些化合物还可以包含荧光染料，用于表达 PSMA 的细胞和肿瘤成像或光动力疗法。